Inherited variation at MC1R and histological characteristics of primary melanoma
- PMID: 25790105
- PMCID: PMC4366050
- DOI: 10.1371/journal.pone.0119920
Inherited variation at MC1R and histological characteristics of primary melanoma
Abstract
Variation in the melanocortin-1receptor (MC1R) gene is associated with pigmentary phenotypes and risk of malignant melanoma. Few studies have reported on MC1R variation with respect to tumor characteristics, especially clinically important prognostic features. We examined associations between MC1R variants and histopathological melanoma characteristics. Study participants were enrolled from nine geographic regions in Australia, Canada, Italy and the United States and were genotyped for MC1R variants classified as high-risk [R] (D84E, R142H, R151C, R160W, and D294H, all nonsense and insertion/deletion) or low-risk [r] (all other nonsynonymous) variants. Tissue was available for 2,160 white participants of the Genes, Environment and Melanoma (GEM) Study with a first incident primary melanoma diagnosis, and underwent centralized pathologic review. No statistically significant associations were observed between MC1R variants and AJCC established prognostic tumor characteristics: Breslow thickness, presence of mitoses or presence of ulceration. However, MC1R was significantly associated with anatomic site of melanoma (p = 0.002) and a positive association was observed between carriage of more than one [R] variant and melanomas arising on the arms (OR = 2.39; 95% CI: 1.40, 4.09). We also observed statistically significant differences between sun-sensitive and sun-resistant individuals with respect to associations between MC1R genotype and AJCC prognostic tumor characteristics. Our results suggest inherited variation in MC1R may play an influential role in anatomic site presentation of melanomas and may differ with respect to skin pigmentation phenotype.
Conflict of interest statement
References
-
- Barnhill RL, Fine JA, Roush GC, Berwick M Predicting five-year outcome for patients with cutaneous melanoma in a population-based study. Cancer. 1996;78: 427–432. - PubMed
-
- Azzola MF, Shaw HM, Thompson JF, Soong SJ, Scolyer RA, Watson GF, et al. Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center. Cancer. 2003;97: 1488–1498. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P30 ES010126/ES/NIEHS NIH HHS/United States
- R01 CA112524/CA/NCI NIH HHS/United States
- R01 CA163251/CA/NCI NIH HHS/United States
- R25 CA147832/CA/NCI NIH HHS/United States
- P30 CA008748/CA/NCI NIH HHS/United States
- P30CA008748/CA/NCI NIH HHS/United States
- R01 CA112243/CA/NCI NIH HHS/United States
- U01CA83180/CA/NCI NIH HHS/United States
- R01CA112243/CA/NCI NIH HHS/United States
- U01 CA083180/CA/NCI NIH HHS/United States
- R25CA147832/CA/NCI NIH HHS/United States
- T32 CA147832/CA/NCI NIH HHS/United States
- R01 CA098438/CA/NCI NIH HHS/United States
- R01CA112243S1/CA/NCI NIH HHS/United States
- R01CA112524S2/CA/NCI NIH HHS/United States
- R01CA098438/CA/NCI NIH HHS/United States
- R01CA112524/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials